San Carlos, CA – Range Biotechnologies, a leading biotechnology research company, announced today the successful completion of its seed funding round, raising an impressive $5.2 million. The funding round was led by prominent venture capital firms Pear VC, Pillar, Civilization Ventures, ARTIS Ventures, and Page One Ventures.

Range Biotechnologies, founded by renowned scientist Dr. Brandon Wilson, aims to revolutionize the field of translational proteomics by unlocking the next stage of human health. The company is dedicated to advancing cutting-edge technologies and methodologies that facilitate a deeper understanding of the human proteome and its implications for disease diagnosis, treatment, and personalized medicine.

The $5.2 million in funding will be utilized to further Range Biotechnologies' research and development efforts. The company plans to expand its team of experts, acquire state-of-the-art laboratory equipment, and accelerate the development of its proprietary proteomic analysis platform. With this investment, Range Biotechnologies will be well-equipped to overcome the significant challenges in translating proteomic data into actionable insights for the benefit of patients and the broader healthcare industry.